1. Home
  2. SRPT vs APPN Comparison

SRPT vs APPN Comparison

Compare SRPT & APPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • APPN
  • Stock Information
  • Founded
  • SRPT 1980
  • APPN 1999
  • Country
  • SRPT United States
  • APPN United States
  • Employees
  • SRPT N/A
  • APPN N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • APPN Computer Software: Prepackaged Software
  • Sector
  • SRPT Health Care
  • APPN Technology
  • Exchange
  • SRPT Nasdaq
  • APPN Nasdaq
  • Market Cap
  • SRPT 2.0B
  • APPN 2.0B
  • IPO Year
  • SRPT 1997
  • APPN 2017
  • Fundamental
  • Price
  • SRPT $18.46
  • APPN $29.92
  • Analyst Decision
  • SRPT Hold
  • APPN Hold
  • Analyst Count
  • SRPT 30
  • APPN 6
  • Target Price
  • SRPT $44.37
  • APPN $34.40
  • AVG Volume (30 Days)
  • SRPT 9.6M
  • APPN 1.2M
  • Earning Date
  • SRPT 08-06-2025
  • APPN 08-07-2025
  • Dividend Yield
  • SRPT N/A
  • APPN N/A
  • EPS Growth
  • SRPT N/A
  • APPN N/A
  • EPS
  • SRPT N/A
  • APPN N/A
  • Revenue
  • SRPT $2,481,531,000.00
  • APPN $657,803,000.00
  • Revenue This Year
  • SRPT $9.41
  • APPN $15.42
  • Revenue Next Year
  • SRPT N/A
  • APPN $11.07
  • P/E Ratio
  • SRPT N/A
  • APPN N/A
  • Revenue Growth
  • SRPT 64.89
  • APPN 13.67
  • 52 Week Low
  • SRPT $10.42
  • APPN $24.00
  • 52 Week High
  • SRPT $138.81
  • APPN $43.33
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 48.03
  • APPN 52.29
  • Support Level
  • SRPT $17.95
  • APPN $28.55
  • Resistance Level
  • SRPT $19.61
  • APPN $31.17
  • Average True Range (ATR)
  • SRPT 1.20
  • APPN 0.88
  • MACD
  • SRPT -0.06
  • APPN 0.15
  • Stochastic Oscillator
  • SRPT 19.69
  • APPN 56.29

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.

Share on Social Networks: